€544.40
1.73%
L&S, Jun 28, 10:54 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Share price

$584.04
+34.78 6.33% 1M
+126.54 27.66% 6M
+121.06 26.15% YTD
+168.83 40.66% 1Y
+391.98 204.09% 3Y
+449.65 334.59% 5Y
+397.83 213.65% 10Y
NYSE, Closing price Fri, Jun 28 2024
ISIN
US58155Q1031
Symbol
MCK
Sector

Key figures

Market capitalization $75.76b
Enterprise Value $78.93b
PER (TTM) P/E ratio 26.11
EV/FCF (TTM) EV/FCF 20.33
EV/Sales (TTM) EV/Sales 0.26
P/S ratio (TTM) P/S ratio 0.25
P/B ratio (TTM) P/B ratio negative
Dividend yield 0.41%
Last dividend (FY24) $2.40
Sales growth (TTM) Sales growth 11.65%
Turnover (TTM) Turnover $308.95b
EBIT (operating result TTM) EBIT $3.93b
Free cash flow (TTM) Free cash flow $3.88b
Cash position $4.59b
EPS (TTM) EPS $22.37
P/E ratio expected 19.72
P/S ratio expected 0.21
EV/Sales expected 0.22
Short interest 1.60%
Show more

Is McKesson a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

McKesson Share analysis

Unlock scores for free

Analyst opinions

20 Analysts have issued a McKesson forecast:

15x Buy
75%
4x Hold
20%
1x Sell
5%

Analyst opinions

20 Analysts have issued a McKesson forecast:

Buy
75%
Hold
20%
Sell
5%

Financial data from McKesson

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
308,951 308,951
12% 12%
100%
- Direct costs 296,749 296,749
12% 12%
96%
12,202 12,202
3% 3%
4%
- Selling and administrative expenses 7,518 7,518
15% 15%
2%
- Research and development costs - -
-
-
4,684 4,684
12% 12%
2%
- Depreciation and amortization 757 757
12% 12%
0%
EBIT (operating result) EBIT 3,927 3,927
12% 12%
1%
Net profit 3,002 3,002
16% 16%
1%

Figures in millions USD.

Don't miss a thing! We will send you all news about the McKesson share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

McKesson Share News

Neutral
Business Wire
4 days ago
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at htt...
Neutral
Business Wire
5 days ago
IRVING, Texas--(BUSINESS WIRE)--McKesson ideaShare hosted nearly 2,700 attendees including independent pharmacy owners and their staff in New Orleans.
Neutral
Business Wire
6 days ago
NEW ORLEANS--(BUSINESS WIRE)--Outcomes, a leader in integrated pharmacy workflow and patient engagement solutions, announced that it will feature a new prescription counting solution, Pill Count, at McKesson ideaShare. By leveraging AI and machine learning, Pill Count™ makes counting pills easier and more accurate. This is the latest solution for Outcomes, a company that offers a full suite of ...
More McKesson News

Company profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Employees 51,000
Founded 1833
Website www.mckesson.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now